Loopwheels invests in clinical indications document to back up why its wheelchair wheels can improve people’s lives
Using an evidence-based approach, Loopwheels is highlighting how its wheelchair wheels can reduce damaging vibrations that wheelchair users experience.
After carrying out testing on its wheels, the company has produced a document – ‘Clinical Indications for Loopwheels’ – which is intended to be used as a guide for healthcare professionals to prove how Loopwheels can aid the end user.
Designed and manufactured in the UK, Loopwheels are wheels with integral suspension which are proven to help with the problems associated with vibrations in wheelchairs. They are available in a range of colours, sizes and with a variety of push rims.
The company ran tests on its wheels after reviewing research about the extent to which vibrations in wheelchairs can be harmful to the user. Results showed that Loopwheels can reduce damaging vibrations by up to 70 percent in the range of 5hz to 13Hz compared to a standard spoked wheel.
Gemma Pearce, Managing Director at Loopwheels, commented: “Our customers have told us that they really want to know that Loopwheels are right for them before committing to buy. By publishing the testing, developing clinical indications and launching a ‘try before you buy’ scheme in the UK, we are helping more of the right people to benefit from these amazing wheels.
“Many people are unaware how debilitating exposure to vibration can be, particularly causing lower back pain and creating fatigue quickly. Loopwheels can play an important role in helping people manage their lives with less pain and long term damage.”
The ‘Try Before You Buy’ scheme enables people in the UK to test the wheels for two weeks for £20, giving users the opportunity to test Loopwheels before they buy them.
In addition, the company created a ‘Payment Plan’ to make Loopwheels more accessible, by allowing users to buy the product at £140 but spreading the cost over six months.
The ‘Clinical Indications for Loopwheels’ document will be launched to a wider audience at Rehacare on the 26th-29th of September, where the company will be exhibiting on stand 6A11.